Health Canada announce first full approval for Moderna COVID-19 vaccine

pharmafile | September 17, 2021 | News story | Medical Communications |ย ย AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrnaย 

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for Pfizer-BioNTech.

The mRNA vaccines from Pfizer-BioNTech and Moderna have been formally granted full approval by Health Canada after the interim order for their vaccines expired. Both jabs are now approved fully for anyone aged 12 and above across Canada.

The Oxford-AstraZeneca vaccine, which remains under an interim order despite the interim order expiring on 16 September, is under review to be transitioned to the Food and Drug Regulations. This includes the original viral vector based vaccine, but does not currently include COVISHIELD, which is the Serum Institute of Indiaโ€™s version of the Oxford-AstraZeneca vaccine.

Advertisement

Read: Moderna and Canada to collaborate on mRNA manufacturing

Read: Pfizer to expand COVID vaccine study in children under 12

The health authority in Canada has also revealed brand name changes to all three of the vaccines. Pfizer-BioNTech will now be referred to as Comirnaty, Moderna as Spikevax, and AstraZeneca as Vaxzevria.

Canadaโ€™s fully vaccinated rate, according to Our World in Data, sits at just under 70%, which means that 26.2 million people have received two jabs of the Oxford-AstraZeneca, Moderna, and Pfizer-BioNTech vaccines, or a single dose of the Johnson & Johnson vaccine, which is approved by Health Canada.

Janssenโ€™s J&J jab also had its interim order expire on 16 September, but like the Oxford-AstraZeneca vaccine, it is under review for transition to the Food and Drug Regulations in Canada.

Doctor photo created by freepik

Related Content

Astra Zeneca Logo

NICE recommends Benralizumab for Rare Form of Vasculitis

The National Institute for Health and Care Excellence (NICE) has recommended AstraZenecaโ€™s benralizumab (Fasenra) as …

NICE approves AstraZenecaโ€™s dual immunotherapy for advanced liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence …

Astra Zeneca Logo

Purpose and people: the enduring power of brand and the evolution of employer identity

Two decades ago, terms like purpose and people were rarely at the forefront of branding …

The Gateway to Local Adoption Series

Latest content